• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.95% Nasdaq Down 2.40%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqGM
    0.56 Down 0.03(5.08%) Jun 29, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.59
    Open:0.61
    Bid:0.54 x 1100
    Ask:0.60 x 2000
    1y Target Est:4.56
    Beta:5.21
    Next Earnings Date:N/A
    Day's Range:0.55 - 0.61
    52wk Range:0.36 - 2.52
    Volume:2,341,921
    Avg Vol (3m):3,180,590
    Market Cap:84.52M
    P/E (ttm):N/A
    EPS (ttm):-0.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTX

    Comparison

    Symbol% ChgMkt Cap
    CYTXDown 5.08%84.52M
    ASTM 0.00%N/A
    BAXDown 1.77%38.40B
    OSIRDown 3.10%645.84M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.29
    Quarterly EPS Est (Jun-15) :-0.03
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback